Pause Video
Research & Technology
Lisata is focused on its robust development portfolio of novel product candidates based on its proprietary field-leading platform technologies. Lisata’s platform technologies are backed by a strong IP portfolio and are “validated” by existing partnerships.
Research & Technology
CendR Platform® – Targeted penetration technology to enhance drug delivery to advanced solid tumors
Advanced solid tumor cancers are types of cancer that have spread beyond the primary cancer site. The tumors in these…
Read More
Research & Technology
CD34+ Cell Technology
CD34+ cell therapy has a well characterized mechanism of action The CD34+ cell therapy process is rapid, economical, and easily…
Read More